Biologicals and small molecule development to target key ectonucleotidases
Biologicals and small molecule development to target key ectonucleotidases for treatment of cancer, autoimmunity, inflammatory disease and metabolic syndrome.
*simoncrobson@gmail.com
Monday - Sunday: 7am - 6pm